Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 304333 | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | KR75K | IM / LA |
Returned to clinic for re-eval on 4/29/25. Tactile fever, headache, bodyaches 24 hours after injection. Progressed to (L) arm tenderness at injection site alongside erythema that started at 48 hours and progressed to time of visit. Unilateral left shoulder pain and bilateral cheek flushing. No angioedema, wheezing on exam concerning for anaphylaxis. Suspect delayed localized reaction. Treated with PRN hydroxizine and hydrocortisone 2.59. 6 cm of circular erythema with no induration to left deltoid. FNP-C
None
None
None
NKDA, NKFA
None